Inclusion Criteria:  GIST diagnosis (c-Kit, CD34, DOG-1) Imatinib-sensitive mutation Non-resectable liver metastases Abscence of extrahepatic disease Period greater than two years between primary tumor and metastases diagnosis Favorable tumor biology (low or intermediate risk)